PRESS RELEASE published on 05/21/2026 at 22:00, 2 months 26 days ago Inventiva présentera lors de la 2026 Jefferies Global Healthcare Conference Inventiva présentera lors de la 2026 Jefferies Global Healthcare Conference à New York City son traitement oral pour la stéatohépatite. Détails de la présentation le 3 juin 2026 Inventiva Lanifibranor Stéatohépatite 2026 Jefferies Global Healthcare Conference Traitement Oral
PRESS RELEASE published on 05/21/2026 at 22:00, 2 months 26 days ago Inventiva to Present at 2026 Jefferies Global Healthcare Conference Inventiva to present at 2026 Jefferies Global Healthcare Conference in New York City. CEO Andrew Obenshain to speak on June 3, 2026, about MASH therapies Clinical-Stage Biopharmaceutical Inventiva Lanifibranor 2026 Jefferies Conference MASH Therapies
BRIEF published on 05/13/2026 at 08:35, 3 months 4 days ago Inventiva présente ses recherches sur le lanifibranor au EASL Congress 2026 Biopharmaceutique Inventiva MASH Lanifibranor EASL Congress 2026
BRIEF published on 05/13/2026 at 08:35, 3 months 4 days ago Inventiva présentera des résumés au congrès EASL 2026 Recherche Biopharmaceutique Inventive Lanifibranor Traitement MASH Congrès EASL 2026
BRIEF published on 05/13/2026 at 08:35, 3 months 4 days ago Inventiva to Present Abstracts at EASL Congress 2026 Biopharmaceutical Research Inventiva Lanifibranor MASH Treatment EASL Congress 2026
BRIEF published on 05/13/2026 at 08:35, 3 months 4 days ago Inventiva presents its research on lanifibranor at the EASL Congress 2026 Biopharmaceutical Inventiva MASH Lanifibranor EASL Congress 2026
PRESS RELEASE published on 05/13/2026 at 08:30, 3 months 4 days ago Inventiva présentera plusieurs abstracts lors de l’EASL Congress 2026 Inventiva présentera plusieurs abstracts lors de l’EASL Congress 2026. Découvrez les détails des présentations et la présence de la société au congrès Biopharmaceutique Inventiva MASH Lanifibranor EASL Congress 2026
PRESS RELEASE published on 05/13/2026 at 08:30, 3 months 4 days ago Inventiva to Present Abstracts at the EASL Congress 2026 Inventiva to present two abstracts at EASL Congress 2026 highlighting Lanifibranor's impact on MASH treatment. Lanifibranor, a pan-PPAR agonist, shows promising results in clinical trials Clinical Trials Inventiva Lanifibranor MASH Treatment EASL Congress 2026
BRIEF published on 04/22/2026 at 22:05, 3 months 24 days ago Inventiva renforce son équipe de direction à l'approche d'une étape clé de la phase 3. Essai De Phase 3 Lanifibranor Développement Du Leadership Traitement MASH Inventiva Biopharmaceutique
BRIEF published on 04/22/2026 at 22:05, 3 months 24 days ago Inventiva renforce sa direction pour la phase 3 du lanifibranor Nomination Biopharmaceutique Direction Phase 3 Lanifibranor
Published on 08/17/2026 at 13:00, 19 minutes ago Eagle Plains Samples up to 269g/t Au at the Pine Channel Gold Project, Saskatchewan
Published on 08/17/2026 at 12:40, 39 minutes ago BioNxt Provides Development, Intellectual Property and Commercial Update Across Sublingual Drug Delivery Pipeline
Published on 08/17/2026 at 12:00, 1 hour 19 minutes ago Banyan Gold Intersects 13.03 g/t Au Over 14.2m at Powerline North, AurMac, Yukon, Canada
Published on 08/17/2026 at 12:00, 1 hour 19 minutes ago NuRAN Wireless Announces Nasdaq Listing and West African US$ 5M Project Kickoff for State-Owned Mobile Operator
Published on 08/17/2026 at 13:05, 13 minutes ago Share buyback: Announcement pursuant to Article 5 (1) (b) and (3) of Regulation (EU) No. 596/2014
Published on 08/17/2026 at 13:05, 14 minutes ago Thunes to Support Fiserv's Real-Time Global Payouts for Platforms
Published on 08/17/2026 at 12:33, 45 minutes ago EQS-Adhoc: fox e-mobility AG: Clean Auditor's Certificate for Annual Financial Statements 2023
Published on 08/17/2026 at 11:55, 1 hour 24 minutes ago Taiwan Weeks 2026 set for Nov. 3-13 with expanded international participation
Published on 08/17/2026 at 09:59, 3 hours 20 minutes ago 260817 BENETEAU Transaction sur actions propres
Published on 08/17/2026 at 08:33, 4 hours 46 minutes ago Covivio - Information on Treasury shares transactions between August 10th, 2026 and August 11th, 2026
Published on 08/17/2026 at 08:33, 4 hours 46 minutes ago Covivio - Déclaration des transactions sur actions propres réalisées du 10 août 2026 au 11 août 2026
Published on 08/17/2026 at 07:30, 5 hours 49 minutes ago Déclaration hebdomadaire d'opérations effectuées du 10 au 14 août 2026
Published on 08/17/2026 at 07:30, 5 hours 49 minutes ago Disclosure of transactions in own shares from August 10 to August 14, 2026
